New research from Monash University provides encouraging evidence of a decline in opioid prescribing in Victoria, with fewer patients being prescribed opioids long-term. However, a concerning rise in opioid prescriptions among younger individuals (ages 15–24) highlights the need for closer examination of prescribing practices and potential interventions.
Key Findings from the Study
Researchers analyzed opioid prescribing data from 526 GP practices across Victoria between 2017 and 2022. Their findings, published in the International Journal of Clinical Pharmacy and Pain Medicine, shed light on both positive trends and areas of concern:
- Overall opioid prescribing has decreased, reflecting a shift towards more cautious prescribing habits.
- Long-term opioid use is declining, with the percentage of patients still on opioids three months after initiation falling from 5.4% in 2018 to 3.6% in 2022.
- New opioid prescriptions among young people (15–24) increased by 69%, signaling a trend that requires further investigation.
- Tapentadol prescriptions surged by 263%, indicating changes in the specific opioids being prescribed.
- Demographic disparities were evident, with variations in prescribing rates based on gender, socio-economic status, and geographic location.
- Opioid use remains highest in regional and remote areas, although there has been a significant decline over time.
Implications for Medical Practitioners
- Young People and Opioid Initiation: The rise in opioid prescriptions among younger individuals raises concerns about potential misuse and long-term dependency. Further research is needed to understand the underlying drivers and whether alternative pain management approaches should be considered.
- Shifts in Opioid Selection: The increased use of tapentadol suggests changes in prescribing habits. Understanding its safety profile and effectiveness compared to traditional opioids is essential for guiding clinical decisions.
- Long-Term Prescribing Declines: The reduction in long-term opioid prescribing is a positive development, indicating greater adherence to opioid stewardship principles. However, continued efforts are needed to support pain management strategies that reduce reliance on opioids.
- Equity in Pain Management: While opioid prescribing decreased among disadvantaged groups, it increased slightly among the least disadvantaged. Ensuring equitable access to pain management resources, including non-opioid alternatives, remains a priority.
- Regional and Remote Considerations: The continued higher rates of opioid prescribing in rural areas may reflect limited access to specialized pain management services. Expanding non-opioid pain treatment options and improving specialist availability in these areas could help address this gap.
Next Steps for Medical Professionals
- Stay informed on evolving opioid prescribing trends and best practices.
- Assess alternative pain management strategies, particularly for younger patients.
- Review the role of newer opioids, such as tapentadol, in clinical practice.
- Consider socio-economic and regional factors when prescribing opioids.
- Engage in ongoing professional development, including CPD courses on opioid stewardship and pain management available on HealthcareLink.
As opioid prescribing continues to evolve, ensuring safe, effective, and equitable pain management remains a key priority. For further insights, refer to the full studies published in International Journal of Clinical Pharmacy and Pain Medicine
Resource:
New research shows positive changes in opioid prescribing, but trend among young people a cause for concern | Monash University
